Position in AMGN
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$1,735,279
+$235,695 QoQ
Shares Held
4,792
+12.4% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#1,361
of 3,140 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority
Sole 19%
Shared 0%
None 81%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Pallas Capital Advisors LLC holds $57,599,993 across 10 Drug Manufacturers - General names. AMGN ranks #8 (3.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
75,730 | $19,233,148 | |
| 2 | LLY |
ELI LILLY & Co
|
9,795 | $11,748,417 | |
| 3 | MRK |
Merck & Co., Inc.
|
62,572 | $8,040,502 | |
| 4 | ABBV |
AbbVie Inc.
|
26,085 | $6,564,029 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
77,353 | $4,457,079 | |
| 6 | BIIB |
Biogen Inc.
|
12,859 | $2,778,315 | |
| 7 | PFE |
Pfizer Inc
|
75,558 | $1,819,436 | |
| 8 | AMGN |
Amgen Inc
This page
|
4,792 | $1,735,279 |
All Filings in AMGN
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,735,279 | 4,792 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $1,499,584 | 4,262 | Shares | Sole | 2026-04-21 | |
| 2025-12-31 | $1,245,087 | 3,804 | Shares | Sole | 2026-01-14 | |
| 2025-09-30 | $1,133,315 | 4,016 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $1,136,663 | 4,071 | Shares | Sole | 2025-07-09 | |
| 2025-03-31 | $1,434,999 | 4,606 | Shares | Sole | 2025-04-14 | |
| 2024-12-31 | $1,252,114 | 4,804 | Shares | Sole | 2025-01-13 | |
| 2024-09-30 | $7,399,874 | 22,966 | Shares | Sole | 2024-10-25 | |
| 2024-06-30 | $7,405,689 | 23,702 | Shares | Sole | 2024-07-22 | |
| 2024-03-31 | $6,524,006 | 22,946 | Shares | Sole | 2024-04-15 | |
| 2023-12-31 | $6,248,017 | 21,693 | Shares | Sole | 2024-01-22 | |
| 2023-09-30 | $5,753,345 | 21,407 | Shares | Sole | 2023-11-01 | |
| 2023-06-30 | $4,258,121 | 19,179 | Shares | Sole | 2023-07-26 | |
| 2023-03-31 | $4,656,588 | 19,262 | Shares | Sole | 2023-05-02 | |
| 2022-12-31 | $4,642,424 | 17,676 | Shares | Sole | 2023-01-24 | |
| 2022-09-30 | $3,989,129 | 17,698 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $4,082,817 | 16,781 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $4,284,808 | 17,719 | Shares | Sole | 2022-04-20 | |
| 2021-12-31 | $3,570,498 | 15,871 | Shares | Sole | 2022-02-01 | |
| 2021-09-30 | $3,164,232 | 14,880 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $2,376,075 | 9,748 | Shares | Sole | 2021-08-11 | |
| 2021-03-31 | $2,020,337 | 8,120 | Shares | Sole | 2021-05-14 | |
| No filing history on record for this holder in this stock. | ||||||